Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201202149 Principal Investigator: Tabchy, Adel
Title: A randomized, two-arm, open-label, multicenter Phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab plus an aromatase inhibitor in first line patients with HER2-positive and hormone receptor-positive advanced (metastatic or locally advanced) breast cancer
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor in patients with HER2-positive and hormone receptor-positive advanced breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)